US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

PHENYLephrine in 0.9 sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1078-2023
Class II · Moderate risk Terminated

PHENYLephrine in 0.9 sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-6008-1 D-1077-2023
Class II · Moderate risk Terminated

rocuronium

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1076-2023
Class II · Moderate risk Terminated

midazolam in dextrose 5%

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-4036-1 D-1075-2023
Class II · Moderate risk Terminated

lidocaine 2%

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc D-1074-2023
Class II · Moderate risk Terminated

ePHEDrine in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-6004-1 D-1073-2023
Class II · Moderate risk Terminated

ketamine in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-3022-1 D-1071-2023
Class II · Moderate risk Terminated

morphine in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-2041-2 D-1068-2023
Class II · Moderate risk Terminated

PHENYLephrine in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-6009-1 D-1066-2023
Class II · Moderate risk Terminated

morphine in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-2040-3 D-1065-2023
Class II · Moderate risk Terminated

morphine in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-2040-1 D-1064-2023
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-2074-1 D-1063-2023
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-2071-7 D-1062-2023
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-2071-5 D-1061-2023
Class II · Moderate risk Terminated

HYDROmorphone in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-2012-1 D-1060-2023
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-2071-4 D-1059-2023
Class II · Moderate risk Terminated

HYDROmorphone in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-2011-1 D-1058-2023
Class II · Moderate risk Terminated

HYDROmorphone in Dextrose 5%

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-2013-1 D-1057-2023
Class II · Moderate risk Terminated

succinylcholine

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-6011-2 D-1056-2023
Class II · Moderate risk Terminated

HYDROmorphone in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-2010-2 D-1055-2023
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility: Lack of validation data for sanitization cycles

Central Admixture Pharmacy Services Inc NDC 71286-2071-3 D-1054-2023